From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
In many cases, a hepatitis B diagnosis can be managed by accredited hepatitis B s100 community prescribers in primary care. But just 10% of people being treated for hepatitis B are currently being managed exclusively in primary care. Accredited s100 prescribers have undertaken additional training to provide quality care for hepatitis B within primary care settings – and it is easy to find one that suits your patient.
There are many potential benefits for treating hepatitis B in the primary care setting. Patients typically receive treatment faster, are less prone to disconnect from health services, and are more likely to adhere to treatment regimes. Plus, it can reduce potential barriers to care – like geographic location or cultural and language barriers.
As a clinician, it is essential you know all the pathways to hepatitis B treatment and management – and can work with your patients to find the best fit for them. As part of this campaign, we’ve produced new resources to support delivering the best care for hepatitis B and referral to hepatitis B s100 community prescribers.
Use our comprehensive suite of resources and tools to support you at each stage of your patient’s diagnosis and referral. s100 prescribers.
Access our supporter kit of social media and digital assets you can use to help inform other clinicians about the primary care treatment pathways for hepatitis B.
Access our supporters kit developed for hepatitis B s100 community prescribers. This includes social media and digital assets you can use to share this campaign and inform others about the HBV s100 prescriber program.
Access the latest iteration of the Viral Hepatitis Mapping Project, to see updated information on hepatitis B prevalence and treatment.
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2026 ASHM